Skip to main content
News BMZ II

News categories: Honors & Funding

ImmunoSensation members among "highly cited researchers"

Five scientists from ImmunoSensation2 are among the world's most cited researchers, annualy published by the information service provider Clarivate Analytics. Once more, Prof. Joachim Schultze (DZNE), Prof. Andreas Schlitzer (LIMES) and Prof. Eicke Latz (DRFZ), Prof. Jonathan Schmid-Burgk (UKB) and Thomas Bieber (UKB) are part of the impressive list.

According to the compilers of the ranking, the people on this list of ‘Highly Cited Researchers’ are among the world's most influential one per cent in their field. The list contains around 6,600 researchers from 59 countries. From Germany, 332 researchers have made it onto the list - including ten from the University of Bonn


The benchmark is the frequency with which scientific publications have been cited by other researchers in the last ten years (period from 2013 to 2023). For the analysis, the creators of the list divided the publications into 20 subject areas and introduced the ‘Cross-Field’ section, which lists researchers who have published in several subject areas.

The ranking is published annually by the ‘Web of Science Group’ and can be found here.

 

Related news

Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry

Back to the news overview